Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SR33805 is a potent antagonist of Ca2+ channel(EC50s of 4.1 nM and 33 nM in depolarized and polarized conditions, respectively)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 68.00 | |
5 mg | In stock | $ 147.00 | |
10 mg | In stock | $ 247.00 | |
25 mg | In stock | $ 446.00 | |
50 mg | In stock | $ 659.00 | |
100 mg | In stock | $ 938.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 183.00 |
Description | SR33805 is a potent antagonist of Ca2+ channel(EC50s of 4.1 nM and 33 nM in depolarized and polarized conditions, respectively) |
Targets&IC50 | Ca2+ channel, L-type:33 nM (EC50, in polarized conditions), Ca2+ channel, L-type:4.1 nM (EC50, in depolarized conditions) |
In vitro | Acute treatment with SR33805 restored the MI-altered cell shortening without affecting the Ca(2+) transient amplitude, suggesting an increase of myofilament Ca(2+) sensitivity in MI myocytes.?Indeed, a SR33805-induced sensitization of myofilament activation was found to be associated with a slight increase in myosin light chain-2 phosphorylation and a more significant decrease on troponin I (TnI) phosphorylation.?Decreased TnI phosphorylation was related to inhibition of protein kinase A activity by SR33805.?Finally, administration of a single intra-peritoneal bolus of SR33805 (20 mg/kg) improved end-systolic strain and fractional shortening of MI hearts[1] |
Molecular Weight | 564.74 |
Formula | C32H40N2O5S |
CAS No. | 121345-64-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (48.69 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SR33805 121345-64-0 Membrane transporter/Ion channel Metabolism Calcium Channel Ca channels channel failing Ca2+ channels Ca2+ SR 33805 SR-33805 acute L-type Inhibitor inhibit depolarized polarized hearts chronic inhibitor